Despite effective and innovative contemporary therapies, survivors of acute myocardial infarction (AMI) remain at high risk for recurrent events and death. In Poland, two distinct nationwide pathways address this risk: KOS-Zawał, a multidisciplinary programme combining early cardiac rehabilitation, lifestyle coun...
M. Banach, M. Kruk, B. Koń et al.· European Heart Journal· 0 citations
High-sensitivity C-reactive protein (hsCRP) is a recognized cardiovascular risk-enhancing factor, yet whether its prognostic value varies across the spectrum of baseline cardiovascular risk defined by the American Heart Association (AHA) PREVENT equations remains unknown.
To evaluate the additive prognosti...
V. Jaiswal, A. Bouras, A. Jaiswal et al.· European Heart Journal· 0 citations
Elevated lipoprotein(a) [Lp(a)] is considered a causal cardiovascular risk factor, yet its independent contribution to coronary artery disease (CAD) in contemporary clinical practice remains uncertain. Determining whether Lp(a) adds predictive value beyond established risk factors is essential for risk stratifica...
B. Sosnowska, J. Lewek, A. Bielecka-Dabrowa et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.